ImageneBio (IMA) Change in Cash (2020 - 2025)

ImageneBio has disclosed Change in Cash across 6 years of filings, most recently posting $72.1 million for Q3 2025.

• Change in Cash for Q3 2025 came in at $72.1 million, up 4.68% year-over-year; the trailing twelve-month figure through Sep 2025 was $16.8 million (up 308.21% YoY), and the FY2024 annual result was -$80.9 million, down 233.99% from the prior year.
• Change in Cash came in at $72.1 million for Q3 2025 at ImageneBio, up from $26.1 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $118.5 million in Q1 2021 to a low of -$185.3 million in Q1 2022.
• The 5-year median for Change in Cash is -$7.2 million (2022), against an average of -$1.7 million.
• Across the five-year window, Change in Cash jumped 2480.06% in 2023 and tumbled 5265.15% in 2024, its largest moves.
• ImageneBio's Change in Cash stood at -$13.7 million in 2021, then jumped by 47.71% to -$7.2 million in 2022, then jumped by 80.67% to -$1.4 million in 2023, then sank by 5265.15% to -$74.2 million in 2024, then surged by 197.23% to $72.1 million in 2025.
• The last three Change in Cash figures came in at $72.1 million (Q3 2025), $26.1 million (Q2 2025), and -$7.2 million (Q1 2025), per Business Quant data.